NeurologyLive Friday 5 — August 20, 2021


Take 5 minutes to catch up on NeurologyLive's highlights from the week ending August 20, 2021.

Welcome to NeurologyLive's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Less Invasive Epilepsy Surgery May Help Turn Candidates Into Consults

In the cover story of NeurologyLive's August 2021 issue, Rohini K. Coorg, MD, offers insight into the recent advances in stereoelectroencephalography and laser ablation that might help convert those who may be candidates for pediatric epilepsy surgery into those who actually proceed with a consultation.

2: Lifestyle Change for Migraine Management: Practical Tips for the Neurologist and PCP, Part 2

Trigger avoidance-only strategies don’t actually help migraine patients improve. In partnership with Ctrl M Health, Stephen D. Silberstein, MD; and William B. Young, MD, offer a list of proactive behaviors that do.

3: NeuroVoices: James Galvin, MD, MPH, on Location and Greenhouse Space Effects on Alzheimer Risk

The director of the Comprehensive Center for Brain Health at the University of Miami Miller School of Medicine provided context on greenhouse spaces and their preventive benefits in Alzheimer disease, as well as how this new social determinant of health should be in the same category as other controllable factors towards AD risk.

4: Peer Exchange: Biomarkers for Monitoring Treatment Response in Relapsing MS

Expert neurologists Fred D. Lublin, MD; Ravi Dukkipati, MD; Gavin Giovannoni, MD; and Lauren Gluck, MD, discuss current and future biomarkers relevant to relapsing multiple sclerosis, including cerebrospinal fluid neurofilament light chain, in episode 13 of the Peer Exchange, "Optimal Management of Relapsing Multiple Sclerosis."

5: Miniature Brain Model Aims to Reduce Cost, Accelerate Drug Discovery for Alzheimer Disease

Yanhong Shi, PhD, director, stem cell biology research, City of Hope National Medical Center, discussed the potential of a new brain organoid model, which was developed to study sporadic Alzheimer disease, its possible implications, and its anticipated use in drug development for sporadic AD, the most common form of the disease


The 3rd Annual International Congress on the Future of Neurology® is coming up! The hybrid meeting, which will showcase the most recent advancements in neurologic disorders, is being held September 17-18, 2021, at the InterContinental New York Barclay. The target audience for this activity is physicians who treat patients with neurologic disorders. Fellows, nurses, nurse practitioners, physician assistants, and other health care professionals interested in the management of patients with neurologic disorders are also invited to participate.

The learning objectives of the program are:

  • Outline current and emerging diagnostic concepts for neurologic disorders
  • Explain clinical evidence for the management of neurologic disorders across multiple lines of care
  • Summarize the mechanism of action of therapeutic agents used to manage neurologic disorders
  • Prepare strategies for early recognition and management of treatment-related toxicities associated with neurologic therapies
  • Apply multidisciplinary care strategies for optimizing patient outcomes in the setting of neurologic disorders
  • Assess recent landmark data from clinical trials in the context of evolving treatment paradigms in neurology
Related Videos
Ro'ee Gilron, PhD
Monica Verduzco-Gutierrez, MD
Shahid Nimjee, MD, PhD
Peter J. McAllister, MD, FAAN
Video 6 - "Utilization of Neuroimaging in Alzheimer’s Disease"
Video 5 - "Contribution of Multiple Pathways to the Development of Alzheimer’s Disease"
Michael Levy, MD, PhD
© 2024 MJH Life Sciences

All rights reserved.